Occurrence, fate, and risk assessment of antibiotics in typical pharmaceutical manufactories and receiving water bodies from different regions

PLoS One. 2023 Jan 20;18(1):e0270945. doi: 10.1371/journal.pone.0270945. eCollection 2023.

Abstract

This study aimed to investigate the presence and persistence of antibiotics in wastewater of four typical pharmaceutical manufactories in China and receiving water bodies and suggest the removal of antibiotics by the wastewater treatment process. It also evaluated the environmental impact of antibiotic residues through wastewater discharge into receiving water bodies. The results indicated that thirteen antibiotics were detected in wastewater samples with concentrations ranging from 57.03 to 726.79 ng/L. Fluoroquinolones and macrolides were the most abundant antibiotic classes found in wastewater samples, accounting for 42.5% and 38.7% of total antibiotic concentrations, respectively, followed by sulfonamides (16.4%) and tetracyclines (2.4%). Erythromycin-H2O, lincomycin, ofloxacin, and trimethoprim were the most frequently detected antibiotics; among these antibiotics, the concentration of ofloxacin was the highest in most wastewater samples. No significant difference was found in different treatment processes used to remove antibiotics in wastewater samples. More than 50% of antibiotics were not completely removed with a removal efficiency of less than 70%. The concentration of detected antibiotics in the receiving water bodies was an order of magnitude lower than that in the wastewater sample due to dilution. An environmental risk assessment showed that lincomycin and ofloxacin could pose a high risk at the concentrations detected in effluents and a medium risk in their receiving water bodies, highlighting a potential hazard to the health of the aquatic ecosystem. Overall, The investigation was aimed to determine and monitor the concentration of selected antibiotics in 4 typical PMFs and their receiving water bodies, and to study the removal of these substances in PMFs. This study will provide significant data and findings for future studies on antibiotics-related pollution control and management in water bodies.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Anti-Bacterial Agents* / analysis
  • China
  • Ecosystem
  • Environmental Monitoring
  • Lincomycin
  • Ofloxacin
  • Pharmaceutical Preparations
  • Risk Assessment
  • Waste Disposal, Fluid
  • Wastewater
  • Water
  • Water Pollutants, Chemical* / analysis

Substances

  • Anti-Bacterial Agents
  • Wastewater
  • Water Pollutants, Chemical
  • Ofloxacin
  • Lincomycin
  • Water
  • Pharmaceutical Preparations

Grants and funding

This study was financially supported by the National Key Research and Development Program of China (2022YFC3902102), the National Natural Science Foundation of China (No. 42107468), the Guangzhou Municipal Science and Technology Project (No. 202201010150), and the Fundamental Research Funds for the Central Public Welfare Research Institutes (No. PM-zx097-202104-089). The above funding has not taken control of the study design. We are grateful to all participants and investigators involving in this project.